A recurring question in livestock genomics is whether a gene that exists in the cow genome is actually functional in cow biology. For GPRC6A, a G protein-coupled receptor known in other species as a nutrient and amino-acid sensor, one useful piece of evidence comes from a 2019 paper in the Journal of Agricultural and Food Chemistry:
“Lysine Enhances the Stimulation of Fatty Acids on Milk Fat Synthesis via the GPRC6A-PI3K-FABP5 Signaling in Bovine Mammary Epithelial Cells.”
The study was authored by Xueying Li, Ping Li, Lulu Wang, Minghui Zhang, and Xuejun Gao. Xueying Li and Xuejun Gao were affiliated with the School of Animal Science, Yangtze University, Jingzhou, China, while Ping Li, Lulu Wang, and Minghui Zhang were affiliated with The Key Laboratory of Dairy Science of Education Ministry, Northeast Agricultural University, Harbin, China. The paper appeared in Journal of Agricultural and Food Chemistry in 2019, volume 67, pages 7005 to 7015, with DOI 10.1021/acs.jafc.9b02160.
The central claim of the paper is that lysine promotes milk-fat synthesis in bovine mammary epithelial cells, BMECs, through a pathway involving:
GPRC6A → PI3K → FABP5 → SREBP-1c → milk-fat synthesis
That pathway is not just decorative biochemistry. The authors test several rungs of the ladder: receptor abundance, receptor localization, pathway activation, knockdown, pharmacological inhibition, and lipid output. Together, these experiments make a strong argument that GPRC6A is functional in bovine mammary epithelial cells.
1. The study begins with primary bovine cells, not a distant surrogate system
The model system matters. This was not a human cell line with bovine gene names painted onto it. The authors used primary bovine mammary epithelial cells isolated from Holstein dairy cows at mid-lactation. They state that BMECs were isolated from mammary gland tissues of Holstein dairy cows and purified from fibroblasts, with epithelial identity confirmed using cytokeratin-18.
This is important because the functional question is cow-specific. If GPRC6A responds to lysine in bovine mammary epithelial cells, then the evidence is directly relevant to cattle lactation biology.
The experimental setup used several treatments:
- Lysine at 0, 0.35, 0.70, 1.05, and 1.40 mM
- Fatty acids, FAs, as a mixture of 100 μM palmitic acid plus 100 μM oleic acid
- PI3K inhibition using LY294002 at 15 μM
- GPRC6A knockdown using siRNA
- FABP5 knockdown using siRNA
This gives the paper a nice causal skeleton: stimulate the system, block the system, knock down the receptor, then ask whether the phenotype survives.
2. GPRC6A is present as a protein in bovine mammary epithelial cells
A gene cannot function through its protein product unless that protein is actually made. The authors tested GPRC6A protein abundance by Western blotting.
In Figure 8A and 8B, BMECs were treated with different lysine concentrations, and GPRC6A protein was measured. The authors report that lysine increased GPRC6A protein up to 0.70 mM, after which the signal declined at higher lysine concentrations.
A key sentence from the Results section says that at low lysine concentrations, lysine “dose-dependently increased the protein level of GPRC6A,” while higher concentrations caused a decrease.
This is the first evidence of functionality: the receptor is not merely predicted from the genome. It is detected as a protein in bovine cells, and its abundance responds to lysine.
Figure detail:
- Figure 8A shows the GPRC6A Western blot.
- Figure 8B quantifies GPRC6A relative protein levels.
- The strongest signal is around 0.70 mM lysine.
- The response is dose-dependent rather than flat background noise.
That dose response is biologically meaningful. It suggests that lysine is not simply present in the medium as a nutrient brick, but is connected to a signaling response involving GPRC6A.
3. GPRC6A localizes to the plasma membrane, where a GPCR should be
For a GPCR, localization is everything. A receptor that never reaches the plasma membrane is a receptor locked in the pantry. GPRC6A is expected to sense extracellular ligands, so its presence at the cell surface is a crucial piece of functional evidence.
The authors tested localization using immunofluorescence staining with an anti-GPRC6A antibody. Their methods describe staining with GPRC6A antibody ab90677, followed by FITC-conjugated secondary antibody, DAPI nuclear staining, confocal microscopy, and ImageJ quantification of GPRC6A signal.
In Figure 8C, GPRC6A appears as a green ring around the cell. The authors describe the signal as being in the “outer circle of the cell,” forming a “thin and circular structure.” They interpret this as plasma membrane localization.
Figure detail:
- Figure 8C shows GPRC6A immunofluorescence in green and DAPI in blue.
- The green signal forms a membrane-like ring.
- Figure 8D quantifies GPRC6A fluorescence per cell.
- The maximum membrane-associated signal occurs at 0.70 mM lysine.
This matters because membrane localization is a functional checkpoint for GPCR biology. The receptor is positioned where it can plausibly detect extracellular lysine or related signals.
4. Lysine activates the downstream lipid-synthesis program
Before asking whether GPRC6A is required, the authors first establish that lysine changes the phenotype of BMECs.
They measure several outputs of milk-fat synthesis:
- SREBP-1c protein expression by Western blot
- nSREBP-1c maturation by Western blot
- Triglyceride secretion using a TG assay kit
- Lipid droplet formation using BODIPY staining
- ImageJ quantification of lipid droplets
In Figure 2, lysine alone increases SREBP-1c, mature nSREBP-1c, triglyceride secretion, and lipid droplet formation, again peaking around 0.70 mM.
In Figure 3, the authors repeat the analysis in the presence of fatty acids. Here the effect is stronger. They report that at 0.70 mM lysine plus FAs, triglyceride content increased by 85.9%, and lipid droplet formation increased by 428.6%, compared with control.
This is the second layer of functionality: lysine produces a real cellular output linked to milk-fat synthesis. The cell is not just flickering a single signaling protein. It is changing lipid metabolism.
5. Lysine and fatty acids cooperate, and FABP5 enters the pathway
The paper then asks whether the lysine effect is connected to fatty-acid handling. The answer is yes, through FABP5, a fatty-acid-binding protein.
In Figure 4, cells were treated with lysine, fatty acids, or lysine plus fatty acids. The lysine-plus-fatty-acid group shows the strongest induction of:
- SREBP-1c
- nSREBP-1c
- FABP5
- TG secretion
- lipid droplet formation
The authors write that SREBP-1c expression and maturation, along with FABP5 expression, were “markedly increased” in cells treated with lysine together with fatty acids.
Figure detail:
- Figure 4A shows Western blots for SREBP-1c, nSREBP-1c, FABP5, and β-actin.
- Figure 4B to 4D quantify these protein changes.
- Figure 4E measures triglyceride secretion.
- Figure 4F and 4G show and quantify lipid droplets.
This supports the model that lysine does not act in isolation. It enhances a fatty-acid-dependent milk-fat synthesis program, with FABP5 serving as a lipid-handling mediator.
6. FABP5 knockdown shows that the lipid-handling branch is required
Association is not causation, so the authors knocked down FABP5 using siRNA.
In Figure 5, FABP5 knockdown strongly reduces FABP5 protein and prevents the lysine-induced increase in SREBP-1c and nSREBP-1c. The authors state that FABP5 knockdown “almost totally abolished” lysine-stimulated SREBP-1c expression and maturation.
Figure detail:
- Figure 5A shows Western blots after FABP5 knockdown.
- Figure 5B confirms reduced FABP5 protein.
- Figure 5C shows loss of SREBP-1c induction.
- Figure 5D shows loss of nSREBP-1c maturation.
This is not direct proof of GPRC6A yet, but it proves that the downstream lipid arm of the pathway is functional and necessary. If GPRC6A is upstream of FABP5, then loss of GPRC6A should collapse the same pathway. That is exactly what the authors test next.
7. PI3K inhibition blocks lysine signaling downstream
The proposed pathway runs through PI3K, so the authors used the PI3K inhibitor LY294002.
In Figure 6, cells were treated with LY294002, lysine, and fatty acids. The authors measured p-AKT/AKT as a readout of PI3K pathway inhibition, along with FABP5, SREBP-1c, and nSREBP-1c.
They report that PI3K inhibition “totally abolished Lys-stimulated” FABP5 expression and SREBP-1c expression/maturation.
Figure detail:
- Figure 6A shows Western blots.
- Figure 6B confirms pathway inhibition using p-AKT/AKT.
- Figure 6C shows reduced FABP5.
- Figure 6D shows reduced SREBP-1c.
- Figure 6E shows reduced nSREBP-1c.
This experiment establishes PI3K as a required signaling bridge between the upstream receptor system and the downstream lipid program. The pathway is no longer just a string of names. It has a pharmacological weak point.
8. The strongest evidence: GPRC6A knockdown collapses PI3K signaling and downstream lipid regulators
The most important experiment in the paper is Figure 7.
Here, the authors directly knock down GPRC6A with siRNA and ask whether lysine can still activate the proposed pathway. The answer is no.
The authors state that GPRC6A knockdown “totally abolished Lys-stimulated PI3K phosphorylation.” They also report loss of FABP5 expression, SREBP-1c expression, and SREBP-1c maturation.
Figure detail:
- Figure 7A shows Western blots for GPRC6A, SREBP-1c, nSREBP-1c, FABP5, PI3K, p-PI3K, and β-actin.
- Figure 7B confirms GPRC6A knockdown.
- Figure 7C shows collapse of p-PI3K/PI3K.
- Figure 7D shows loss of FABP5 induction.
- Figure 7E shows loss of SREBP-1c induction.
- Figure 7F shows loss of nSREBP-1c maturation.
This is the functional centerpiece. If GPRC6A were merely present but irrelevant, knocking it down would not erase the lysine response. Instead, the pathway loses its upstream spark.
The authors summarize this directly: lysine stimulates PI3K and downstream signaling in a GPRC6A-dependent manner.
That is strong evidence for functionality in cattle cells.
9. The evidence supports function, but not every possible mechanism is proven
The paper makes a persuasive case that bovine GPRC6A is functional in BMECs. It shows:
- GPRC6A protein is present.
- GPRC6A abundance responds to lysine.
- GPRC6A localizes to the plasma membrane.
- Lysine activates PI3K signaling.
- Lysine activates FABP5 and SREBP-1c.
- Lysine increases triglyceride secretion and lipid droplets.
- PI3K inhibition blocks downstream signaling.
- FABP5 knockdown blocks SREBP-1c activation.
- GPRC6A knockdown collapses PI3K phosphorylation and downstream signaling.
But there is one important caveat: the study does not directly prove that lysine physically binds bovine GPRC6A. There is no ligand-binding assay, receptor rescue experiment, receptor mutant analysis, calcium flux assay, cAMP assay, or β-arrestin recruitment assay.
So the careful conclusion is:
This paper shows that GPRC6A is functionally required for lysine-stimulated PI3K-FABP5-SREBP-1c signaling and milk-fat synthesis markers in bovine mammary epithelial cells. It strongly supports GPRC6A functionality in cattle, although it does not directly demonstrate lysine-GPRC6A binding.
10. Why this matters for the cow genome
For genome annotation, the question is often whether a gene is merely predicted or whether it has biological life. In this paper, GPRC6A passes several functionality tests.
It is expressed.
It is translated.
It reaches the plasma membrane.
It responds to lysine.
Its knockdown destroys a signaling response.
Its pathway connects to a biologically meaningful bovine phenotype: milk-fat synthesis.
That is a substantial evidence stack. Not perfect, but far beyond annotation-by-guesswork.
In short, GPRC6A in cow is not just a genomic wallflower. In bovine mammary epithelial cells, it behaves like a working receptor in a nutrient-sensitive signaling pathway controlling lipid synthesis.
